{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:28:10Z","timestamp":1793935690328,"version":"4.8.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.drudis.2026.104805","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:56:39Z","timestamp":1789602999000},"page":"104805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathway-driven target prioritisation in drug discovery"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-3120","authenticated-orcid":false,"given":"Polina","family":"Rusina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Rapaport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shameer","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104805_b0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","article-title":"From target discovery to clinical drug development with human genetics","volume":"620","author":"Trajanoska","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104805_b0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104805_b0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104805_b0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-biodatasci-101424-120950","article-title":"Network-based approaches for drug target identification","volume":"8","author":"Koutsandreas","year":"2025","journal-title":"Annu Rev Biomed Data Sci"},{"key":"10.1016\/j.drudis.2026.104805_b0025","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0030","doi-asserted-by":"crossref","first-page":"D587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae069","article-title":"Benchmarking enrichment analysis methods with the disease pathway network","volume":"25","author":"Buzzao","year":"2024","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.drudis.2026.104805_b0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tig.2023.01.003","article-title":"Interpreting omics data with pathway enrichment analysis","volume":"39","author":"Zhao","year":"2023","journal-title":"Trends Genet"},{"key":"10.1016\/j.drudis.2026.104805_b0045","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0050","doi-asserted-by":"crossref","first-page":"D679","DOI":"10.1093\/nar\/gkad960","article-title":"WikiPathways 2024: next generation pathway database","volume":"52","author":"Agrawal","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0055","article-title":"The Gene Ontology knowledgebase in 2023","volume":"224","author":"Consortium","year":"2023","journal-title":"Genetics"},{"key":"10.1016\/j.drudis.2026.104805_b0060","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3389\/fgene.2019.01203","article-title":"The impact of pathway database choice on statistical enrichment analysis and predictive modeling","volume":"10","author":"Mubeen","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.drudis.2026.104805_b0065","first-page":"3","article-title":"ComPath: an ecosystem for exploring, analyzing, and curating mappings across pathway databases","volume":"5","author":"Domingo-Fern\u00e1ndez","year":"2018","journal-title":"npj Syst Biol Appl"},{"key":"10.1016\/j.drudis.2026.104805_b0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.drudis.2026.104805_b0075","first-page":"D489","article-title":"Pathway Commons 2019 update: integration, analysis and exploration of pathway data","volume":"48","author":"Rodchenkov","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0080","doi-asserted-by":"crossref","first-page":"W168","DOI":"10.1093\/nar\/gkad393","article-title":"Enrichr-KG: bridging enrichment analysis across multiple libraries","volume":"51","author":"Evangelista","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0085","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"G:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0090","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209923","article-title":"Integrated intra- and intercellular signaling knowledge for multicellular omics analysis","volume":"17","author":"T\u00fcrei","year":"2021","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.drudis.2026.104805_b0095","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0100","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104805_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102206","article-title":"Beltrao P Network analysis of genome-wide association studies for drug target prioritisation","volume":"71","author":"Barrio-Hernandez","year":"2022","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.drudis.2026.104805_b0110","article-title":"Identification of transcriptional regulators using a combined disease module identification and prize-collecting Steiner tree approach","volume":"1","author":"Galindez","year":"2025","journal-title":"Netw Syst Med"},{"key":"10.1016\/j.drudis.2026.104805_b0115","doi-asserted-by":"crossref","first-page":"20970","DOI":"10.1038\/s41598-020-77847-9","article-title":"Network and pathway expansion of genetic disease associations identifies successful drug targets","volume":"10","author":"MacNamara","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104805_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13059-019-1790-4","article-title":"Identifying significantly impacted pathways: a comprehensive review and assessment","volume":"20","author":"Nguyen","year":"2019","journal-title":"Genome Biol"},{"key":"10.1016\/j.drudis.2026.104805_b0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0130","doi-asserted-by":"crossref","first-page":"W307","DOI":"10.1093\/nar\/gkaa236","article-title":"SPEED2: inferring upstream pathway activity from differential gene expression","volume":"48","author":"Rydenfelt","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0135","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1101\/gr.240663.118","article-title":"Benchmark and integration of resources for the estimation of human transcription factor activities","volume":"29","author":"Garcia-Alonso","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.drudis.2026.104805_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/pro.4218","article-title":"PANTHER: making genome-scale phylogenetics accessible to all","volume":"31","author":"Thomas","year":"2022","journal-title":"Protein Sci"},{"key":"10.1016\/j.drudis.2026.104805_b0145","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"key":"10.1016\/j.drudis.2026.104805_b0150","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0155","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.drudis.2026.104805_b0160","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104805_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btac757","article-title":"GSEApy: a comprehensive package for performing gene set enrichment analysis in Python","volume":"39","author":"Fang","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104805_b0170","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/bioinformatics\/btac076","article-title":"blitzGSEA: efficient computation of gene set enrichment analysis through gamma distribution approximation","volume":"38","author":"Lachmann","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2026.104805_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1264656","article-title":"PSF toolkit: an R package for pathway curation and topology-aware analysis","volume":"14","author":"Hakobyan","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.drudis.2026.104805_b0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12859-022-04884-8","article-title":"SEMgsa: topology-based pathway enrichment analysis with structural equation models","volume":"23","author":"Grassi","year":"2022","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.drudis.2026.104805_b0185","doi-asserted-by":"crossref","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","article-title":"Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery","volume":"53","author":"Buniello","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0190","doi-asserted-by":"crossref","first-page":"D1287","DOI":"10.1093\/nar\/gkae1050","article-title":"canSAR 2024\u2014an update to the public drug discovery knowledgebase","volume":"53","author":"Gingrich","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2026.104805_b0195","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16088","article-title":"Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets","volume":"11","author":"Dobbs Spendlove","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.drudis.2026.104805_b0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bib\/bbw136","article-title":"Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning","volume":"19","author":"Shameer","year":"2017","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.drudis.2026.104805_b0205","article-title":"BioMaze: benchmarking and enhancing large language models for biological pathway reasoning","author":"Zhao","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.drudis.2026.104805_b0210","article-title":"Bioinformatics-native AI agent skills for genomics, pharmacogenomics and metagenomics","author":"ClawBio contributors.","year":"2025","journal-title":"ClawBio"},{"issue":"5","key":"10.1016\/j.drudis.2026.104805_b0215","article-title":"Drug development advances in human genetics-based targets","volume":"2024","author":"Zhang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.drudis.2026.104805_b0220","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41588-019-0456-1","article-title":"A genetics-led approach defines the drug target landscape of 30 immune-related traits","volume":"51","author":"Fang","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.drudis.2026.104805_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.758440","article-title":"Genomic evidence supports the recognition of endometriosis as an inflammatory systemic disease and reveals disease-specific therapeutic potentials of targeting neutrophil degranulation","volume":"13","author":"Bao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2026.104805_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0329101","article-title":"Integrative molecular network analysis of genetic risk factors to infer biomarkers and therapeutic targets for rheumatoid arthritis","volume":"20","author":"Alsaedi","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104805_b0235","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1038\/s41467-021-25805-y","article-title":"Differentially expressed genes reflect disease-induced rather than disease-causing changes in the transcriptome","volume":"12","author":"Porcu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302696","article-title":"Assessment of gene set enrichment analysis using curated RNA-seq-based benchmarks","volume":"19","author":"Candia","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104805_b0245","article-title":"A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration","volume":"8","author":"Wu","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2026.104805_b0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s44161-023-00278-y","article-title":"Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis","volume":"2","author":"Amadori","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.drudis.2026.104805_b0255","doi-asserted-by":"crossref","DOI":"10.1002\/alz.71008","article-title":"Integrated phenotypic and proteomic screening identifies top-tier Alzheimer\u2019s disease therapeutic targets","volume":"21","author":"Cary","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.drudis.2026.104805_b0260","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41467-024-44994-w","article-title":"Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade","volume":"15","author":"Francis","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0265","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1038\/s44318-026-00744-w","article-title":"Deep single-cell decoding of human pancreatic islets reveals T2D \u03b2-cell gene expression defects","volume":"45","author":"Bandesh","year":"2026","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2026.104805_b0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1878-0261.13550","article-title":"Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications","volume":"18","author":"Hijazo-Pechero","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.drudis.2026.104805_b0275","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s42255-026-01543-7","article-title":"A data-driven framework reconstructs the molecular continuum of human MASLD progression","volume":"8","author":"Kamzolas","year":"2026","journal-title":"Nat Metab"},{"key":"10.1016\/j.drudis.2026.104805_b0280","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-024-07350-y","article-title":"Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers","volume":"629","author":"Ferretti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104805_b0285","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1038\/s41467-025-58366-5","article-title":"Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression","volume":"16","author":"Lu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0290","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1038\/s41467-026-69695-4","article-title":"Combination of PARP and KRASG12D inhibitors enhances therapeutic efficacy by exploiting vulnerabilities in PDAC","volume":"17","author":"Xu","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0295","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.cell.2022.05.013","article-title":"Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq","volume":"185","author":"Replogle","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104805_b0300","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1038\/s41467-024-51859-9","article-title":"Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and benchmark","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2026.104805_b0305","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s43856-025-01150-9","article-title":"Discovering anticancer drug target combinations via network-informed signaling-based approach","volume":"5","author":"Yavuz","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.drudis.2026.104805_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1014122","article-title":"Ten common mistakes that could ruin your enrichment analysis","volume":"22","author":"Bora","year":"2026","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.drudis.2026.104805_b0315","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41576-025-00904-4","article-title":"Genomics of drug target prioritization for complex diseases","volume":"27","author":"Chen","year":"2026","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2026.104805_b0320","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06139-9","article-title":"Transfer learning enables predictions in network biology","volume":"618","author":"Theodoris","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2026.104805_b0325","article-title":"Self-supervised learning for a gene program-centric view of cell states","author":"Moullet","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104805_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2026.104650","article-title":"AI agents in drug discovery: applications and case studies","volume":"31","author":"Huynh","year":"2026","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2026.104805_b0335","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1038\/s41467-024-50385-y","article-title":"A robust cis-Mendelian randomization method with application to drug target discovery","volume":"15","author":"Lin","year":"2024","journal-title":"Nat Commun"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626002102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:08:00Z","timestamp":1793934480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626002102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1359644626002102"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104805","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathway-driven target prioritisation in drug discovery","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104805"}}